AORT (Artivion Inc) Company Projected Revenue

Brandmark of Artivion Inc (AORT)

Future sales volumes for Artivion, Inc. (AORT) demonstrate the impact of its monopoly on cryopreserved tissues and On-X stents, with the 0.48 mark characterizing this parameter. Rising demand for cardiac surgery is bolstered by strict FDA oversight and physician confidence in patents, while the company's environmental focus is based on rigorous sterility and the safe disposal of biomaterials.

AORT - Artivion Corp Company Expected Sales Volume over the range 07/04/2022 - 11/18/2026

Analytical breakdowns and data insights for company Artivion Inc (AORT)

- current price and projected stock value:
Fundamental company analysis:artivion.com
Brand item of CryoLife

Artivion, Inc. (AORT) provides hospitals with critical cardiac surgery materials, including transplant tissues and stents, ensuring stable demand. By analyzing the company's prospective sales dynamics, an investor gains a primary issuer screening tool that aggregates market transactions into a single trend, allowing for an assessment of future revenue potential and the determination of fundamental business stability through the context of current values without a deep audit.

Analysis of competing companies

Company Projected Revenue Boston Scientific Corp (BSX)|EW - Company Expected Sales Volume|Projected Sales Volume RMD (resmed.com)|PODD - Company Future Sales Volume|Zimmer Biomet Holdings, Inc. - Projected Sales Volume|COO (The Cooper Companies) - Company Revenue Forecast|ALGN: Projected Sales Volume|Company Revenue Forecast GMED|TMDX (TransMedics Corp) - Projected Sales Volume|ATEC Spine (ATEC) - Company Future Sales|Projected Sales Volume ENOV|Company Future Sales Volume Integra LifeSciences IART|Projected Sales Volume ESTA (establishmentlabs.com)|Projected Sales Volume Beta Bionics, Inc. BBNX|IRMD - Company Projected Revenue|EMBC: Company Projected Revenue|TNDM (Tandem Diabetes Care) - Company Future Sales Volume|AxoGen, Inc. - Company Future Revenue|SIBN (SI-BONE Medical) - Projected Sales Volume|Company Expected Sales Volume Orthofix Medical OFIX|Company Future Sales Volume BVS (Bioventus Inc)|OrthoPediatrics Inc. (KIDS) - Company Sales Forecast|Treace Corp - Company Future Sales Volume|Projected Sales Volume Strata Critical Medical Inc SRTA|Carlsmed, Inc. - Projected Sales Volume|Company Future Sales RxSight Inc RXST|ClearPoint Neuro (CLPT) - Company Projected Revenue|Company Expected Revenue STXS (Stereotaxis Corporation)|Company Projected Revenue neurostar.com|Company Future Sales Volume Sight Sciences, Inc. (SGHT)|Projected Sales Volume OBIO|ANIK - Company Expected Sales Volume|Company Projected Revenue InspireMD, Inc. NSPR|ZJYL: Company Revenue Forecast|VANI: Company Future Sales Volume|Xtant Medical Holdings, Inc. - Company Projected Revenue Volume|NeuroOne Corp (NMTC) - Company Projected Revenue|Company Future Sales Volume Modular Med|Company Projected Revenue myomo.com|Company Revenue Forecast COCH (Envoy Medical, Inc.)|Company Future Sales Volume VVOS (Vivos Therapeutics)|Company Projected Revenue NVNO (enVVeno Medical Corp.)|Sintx Technologies, Inc. - Company Future Sales Volume|Tenon Medical Inc. (TNON) - Company Expected Sales Volume|LFWD - Company Projected Revenue|AMIX (Autonomix Medical) - Company Revenue Forecast|IVF: Projected Sales Volume|BBLG (Bone Biologics) - Company Projected Revenue|Company Projected Revenue Axonics Inc.|Company Expected Sales Volume Biolase, Inc. BIOL|Company Projected Revenue Dynatronics Corp. (DYNT)|FNA (Paragon 28 Corp) - Company Future Revenue|Company Projected Revenue invobioscience.com INVO